Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chonglou Jiedu tincture (also known as Chonglou Jiedu Ding) is a traditional Chinese patent medicine formulated as a topical liquid tincture. Developed and manufactured by Guizhou Shengjitang Pharmaceutical, the formulation is primarily composed of Paridis Rhizoma (Chonglou), Radix Aconiti Kusnezoffii (Caowu), Artemisiae Argyi Folium (Aiye), Acori Tatarinowii Rhizoma (Shichangpu), garlic, and natural borneol. The tincture is approved in China for clearing heat, detoxifying, resolving stasis, and relieving pain. It is clinically utilized for the topical treatment of herpes zoster, skin pruritus, insect bite dermatitis, and mumps.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chonglou Jiedu tincture.